FDA Grants Breakthrough Device Designation To Tempus’ HLA-LOH Companion Diagnostic Test
CHICAGO--(BUSINESS WIRE)-- Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its...
Read more








